$ATRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adhera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adhera Therapeutics, Inc.. Get notifications about new insider transactions in Adhera Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Sell | S | 14.30 | 20,558 | 293,979 | 19,606 | 40.2 K to 19.6 K (-51.19 %) |
| Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Buy | M | 9.36 | 28,058 | 262,623 | 40,164 | 12.1 K to 40.2 K (+231.77 %) |
| Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Sell | S | 14.50 | 3,900 | 56,550 | 12,106 | 16 K to 12.1 K (-24.37 %) |
| Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Buy | M | 9.36 | 5,954 | 55,729 | 16,006 | 10.1 K to 16 K (+59.23 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.15 | 200 | 2,830 | 312,787 | 313 K to 312.8 K (-0.06 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.00 | 200 | 2,800 | 312,987 | 313.2 K to 313 K (-0.06 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.95 | 400 | 5,580 | 313,187 | 313.6 K to 313.2 K (-0.13 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.90 | 500 | 6,950 | 313,587 | 314.1 K to 313.6 K (-0.16 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.88 | 200 | 2,776 | 314,087 | 314.3 K to 314.1 K (-0.06 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.85 | 800 | 11,080 | 314,287 | 315.1 K to 314.3 K (-0.25 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.84 | 200 | 2,768 | 315,087 | 315.3 K to 315.1 K (-0.06 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.80 | 300 | 4,140 | 315,287 | 315.6 K to 315.3 K (-0.10 %) |
| Sep 05 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.76 | 200 | 2,752 | 315,587 | 315.8 K to 315.6 K (-0.06 %) |
| Aug 28 2007 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Financial Off ... | Payment of Exercise | F | 14.02 | 1,321 | 18,520 | 46,381 | 47.7 K to 46.4 K (-2.77 %) |
| Aug 16 2007 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Sell | S | 14.19 | 3,000 | 42,567 | 26,657 | 29.7 K to 26.7 K (-10.12 %) |
| Aug 14 2007 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Chief Actg Officer, ... | Payment of Exercise | F | 14.17 | 881 | 12,484 | 18,885 | 19.8 K to 18.9 K (-4.46 %) |
| Aug 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.01 | 1,100 | 17,611 | 315,787 | 316.9 K to 315.8 K (-0.35 %) |
| Aug 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.00 | 2,900 | 46,400 | 316,887 | 319.8 K to 316.9 K (-0.91 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.85 | 100 | 1,285 | 319,787 | 319.9 K to 319.8 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.80 | 100 | 1,280 | 319,887 | 320 K to 319.9 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.76 | 169 | 2,156 | 319,987 | 320.2 K to 320 K (-0.05 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.75 | 100 | 1,275 | 320,156 | 320.3 K to 320.2 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.67 | 131 | 1,660 | 320,256 | 320.4 K to 320.3 K (-0.04 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.64 | 300 | 3,792 | 320,387 | 320.7 K to 320.4 K (-0.09 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.63 | 100 | 1,263 | 320,687 | 320.8 K to 320.7 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.62 | 347 | 4,379 | 320,787 | 321.1 K to 320.8 K (-0.11 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.60 | 153 | 1,928 | 321,134 | 321.3 K to 321.1 K (-0.05 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.59 | 200 | 2,518 | 321,287 | 321.5 K to 321.3 K (-0.06 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.58 | 30 | 377 | 321,487 | 321.5 K to 321.5 K (-0.01 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.56 | 80 | 1,005 | 321,517 | 321.6 K to 321.5 K (-0.02 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.55 | 390 | 4,895 | 321,597 | 322 K to 321.6 K (-0.12 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.53 | 100 | 1,253 | 321,987 | 322.1 K to 322 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.51 | 100 | 1,251 | 322,087 | 322.2 K to 322.1 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.49 | 100 | 1,249 | 322,187 | 322.3 K to 322.2 K (-0.03 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.42 | 200 | 2,484 | 322,287 | 322.5 K to 322.3 K (-0.06 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.42 | 53 | 658 | 322,487 | 322.5 K to 322.5 K (-0.02 %) |
| Aug 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.28 | 247 | 3,033 | 322,540 | 322.8 K to 322.5 K (-0.08 %) |
| Jul 27 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 12.28 | 800 | 9,824 | 436,159 | 437 K to 436.2 K (-0.18 %) |
| Jul 27 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 12.32 | 1,000 | 12,320 | 436,959 | 438 K to 437 K (-0.23 %) |
| Jul 27 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 12.23 | 2,000 | 24,460 | 437,959 | 440 K to 438 K (-0.45 %) |
| Jul 27 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 12.11 | 2,000 | 24,220 | 439,959 | 442 K to 440 K (-0.45 %) |
| Jul 18 2007 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Chief Actg Officer, ... | Payment of Exercise | F | 11.89 | 272 | 3,234 | 19,766 | 20 K to 19.8 K (-1.36 %) |
| Jul 23 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Payment of Exercise | F | 12.61 | 11,103 | 140,009 | 441,959 | 453.1 K to 442 K (-2.45 %) |
| Jul 11 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.05 | 500 | 6,025 | 322,287 | 322.8 K to 322.3 K (-0.15 %) |
| Jul 11 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.02 | 200 | 2,404 | 322,787 | 323 K to 322.8 K (-0.06 %) |
| Jul 11 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.01 | 800 | 9,608 | 322,987 | 323.8 K to 323 K (-0.25 %) |
| Jul 11 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.00 | 500 | 6,000 | 323,787 | 324.3 K to 323.8 K (-0.15 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.06 | 200 | 2,212 | 324,287 | 324.5 K to 324.3 K (-0.06 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.94 | 100 | 1,094 | 324,487 | 324.6 K to 324.5 K (-0.03 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.92 | 100 | 1,092 | 324,587 | 324.7 K to 324.6 K (-0.03 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.90 | 500 | 5,450 | 324,687 | 325.2 K to 324.7 K (-0.15 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.86 | 100 | 1,086 | 325,187 | 325.3 K to 325.2 K (-0.03 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Financial Off ... | Payment of Exercise | F | 10.98 | 192 | 2,108 | 47,702 | 47.9 K to 47.7 K (-0.40 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Chief Actg Officer, ... | Grant | A | 0.00 | 4,179 | 0 | 20,038 | 15.9 K to 20 K (+26.35 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Chief Actg Officer, ... | Payment of Exercise | F | 10.98 | 101 | 1,109 | 15,859 | 16 K to 15.9 K (-0.63 %) |
| Jul 03 2007 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Payment of Exercise | F | 10.98 | 201 | 2,207 | 42,195 | 42.4 K to 42.2 K (-0.47 %) |
| Jun 18 2007 | MRNA | Marina Biotech, In ... | BAYH SUSAN B | Director | Option Exercise | A | 11.60 | 9,500 | 110,200 | 32,500 | |
| Jun 18 2007 | MRNA | Marina Biotech, In ... | BAYH SUSAN B | Director | Grant | A | 0.00 | 4,500 | 0 | 24,735 | 20.2 K to 24.7 K (+22.24 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Option Exercise | A | 11.60 | 4,000 | 46,400 | 26,000 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Grant | A | 0.00 | 2,000 | 0 | 105,612 | 103.6 K to 105.6 K (+1.93 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | A | 11.60 | 4,000 | 46,400 | 46,000 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Grant | A | 0.00 | 2,000 | 0 | 325,287 | 323.3 K to 325.3 K (+0.62 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | A | 11.60 | 10,000 | 116,000 | 106,000 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Grant | A | 0.00 | 5,000 | 0 | 114,041 | 109 K to 114 K (+4.59 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | A | 11.60 | 10,000 | 116,000 | 82,500 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Grant | A | 0.00 | 5,000 | 0 | 30,833 | 25.8 K to 30.8 K (+19.36 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Option Exercise | A | 11.60 | 9,500 | 110,200 | 37,000 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Grant | A | 0.00 | 5,922 | 0 | 29,657 | 23.7 K to 29.7 K (+24.95 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Option Exercise | A | 11.60 | 13,000 | 150,800 | 43,500 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Grant | A | 0.00 | 7,422 | 0 | 51,392 | 44 K to 51.4 K (+16.88 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | FERRIER IAN R | Director | Option Exercise | A | 11.60 | 4,000 | 46,400 | 24,000 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | FERRIER IAN R | Director | Grant | A | 0.00 | 3,422 | 0 | 12,657 | 9.2 K to 12.7 K (+37.05 %) |
| Jun 12 2007 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Payment of Exercise | F | 11.77 | 1,322 | 15,560 | 42,396 | 43.7 K to 42.4 K (-3.02 %) |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | CROSS ALEXANDER D | Director | Option Exercise | A | 11.60 | 11,500 | 133,400 | 38,000 | |
| Jun 15 2007 | MRNA | Marina Biotech, In ... | CROSS ALEXANDER D | Director | Grant | A | 0.00 | 5,500 | 0 | 28,000 | 22.5 K to 28 K (+24.44 %) |
| Jun 08 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 10.95 | 400 | 4,380 | 453,062 | 453.5 K to 453.1 K (-0.09 %) |
| Jun 08 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 10.93 | 2,000 | 21,864 | 453,462 | 455.5 K to 453.5 K (-0.44 %) |
| Jun 08 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 11.01 | 2,000 | 22,020 | 455,462 | 457.5 K to 455.5 K (-0.44 %) |
| Jun 08 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 11.31 | 2,000 | 22,620 | 457,462 | 459.5 K to 457.5 K (-0.44 %) |
| Jun 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.20 | 500 | 6,100 | 323,287 | 323.8 K to 323.3 K (-0.15 %) |
| Jun 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.15 | 400 | 4,860 | 323,787 | 324.2 K to 323.8 K (-0.12 %) |
| Jun 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.12 | 500 | 6,060 | 324,187 | 324.7 K to 324.2 K (-0.15 %) |
| Jun 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.10 | 1,100 | 13,310 | 324,687 | 325.8 K to 324.7 K (-0.34 %) |
| Jun 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.05 | 500 | 6,025 | 325,787 | 326.3 K to 325.8 K (-0.15 %) |
| May 29 2007 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Sr VP, Operations & ... | Payment of Exercise | F | 11.76 | 661 | 7,773 | 23,839 | 24.5 K to 23.8 K (-2.70 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.99 | 100 | 1,399 | 326,287 | 326.4 K to 326.3 K (-0.03 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.95 | 100 | 1,395 | 326,387 | 326.5 K to 326.4 K (-0.03 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.75 | 400 | 5,500 | 326,487 | 326.9 K to 326.5 K (-0.12 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.66 | 100 | 1,366 | 326,887 | 327 K to 326.9 K (-0.03 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.64 | 400 | 5,456 | 326,987 | 327.4 K to 327 K (-0.12 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.63 | 100 | 1,363 | 327,387 | 327.5 K to 327.4 K (-0.03 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.62 | 100 | 1,362 | 327,487 | 327.6 K to 327.5 K (-0.03 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.61 | 200 | 2,722 | 327,587 | 327.8 K to 327.6 K (-0.06 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.60 | 400 | 5,440 | 327,787 | 328.2 K to 327.8 K (-0.12 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.59 | 300 | 4,077 | 328,187 | 328.5 K to 328.2 K (-0.09 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.58 | 200 | 2,716 | 328,487 | 328.7 K to 328.5 K (-0.06 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.56 | 400 | 5,424 | 328,687 | 329.1 K to 328.7 K (-0.12 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.55 | 100 | 1,355 | 329,087 | 329.2 K to 329.1 K (-0.03 %) |
| May 09 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.51 | 100 | 1,351 | 329,187 | 329.3 K to 329.2 K (-0.03 %) |
| Apr 24 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 10.99 | 5,000 | 54,950 | 93,699 | |
| Apr 24 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 13.22 | 5,000 | 66,109 | 23,165 | 28.2 K to 23.2 K (-17.75 %) |
| Apr 24 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.99 | 5,000 | 54,950 | 28,165 | 23.2 K to 28.2 K (+21.58 %) |
| Apr 20 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 12.15 | 1,850 | 22,478 | 459,462 | 461.3 K to 459.5 K (-0.40 %) |
| Apr 20 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 11.96 | 2,000 | 23,920 | 461,312 | 463.3 K to 461.3 K (-0.43 %) |
| Apr 20 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 12.00 | 2,000 | 24,000 | 463,312 | 465.3 K to 463.3 K (-0.43 %) |
| Apr 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.83 | 200 | 2,166 | 329,287 | 329.5 K to 329.3 K (-0.06 %) |
| Apr 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.82 | 100 | 1,082 | 329,487 | 329.6 K to 329.5 K (-0.03 %) |
| Apr 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.77 | 400 | 4,308 | 329,587 | 330 K to 329.6 K (-0.12 %) |
| Apr 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.71 | 100 | 1,071 | 329,987 | 330.1 K to 330 K (-0.03 %) |
| Apr 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.70 | 100 | 1,070 | 330,087 | 330.2 K to 330.1 K (-0.03 %) |
| Apr 04 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.66 | 100 | 1,066 | 330,187 | 330.3 K to 330.2 K (-0.03 %) |
| Mar 12 2007 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Buy | P | 10.10 | 2,000 | 20,195 | 22,500 | 20.5 K to 22.5 K (+9.76 %) |
| Mar 12 2007 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Buy | P | 10.20 | 3,000 | 30,600 | 20,500 | 17.5 K to 20.5 K (+17.14 %) |
| Mar 12 2007 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Buy | P | 10.34 | 3,000 | 31,020 | 17,500 | 14.5 K to 17.5 K (+20.69 %) |
| Mar 09 2007 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 10.73 | 2,000 | 21,467 | 103,612 | 101.6 K to 103.6 K (+1.97 %) |
| Mar 09 2007 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Buy | P | 10.75 | 2,000 | 21,500 | 14,500 | 12.5 K to 14.5 K (+16.00 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.42 | 100 | 1,142 | 330,287 | 330.4 K to 330.3 K (-0.03 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.25 | 200 | 2,250 | 330,387 | 330.6 K to 330.4 K (-0.06 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.20 | 300 | 3,360 | 330,587 | 330.9 K to 330.6 K (-0.09 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.17 | 100 | 1,117 | 330,887 | 331 K to 330.9 K (-0.03 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.14 | 100 | 1,114 | 330,987 | 331.1 K to 331 K (-0.03 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.11 | 100 | 1,111 | 331,087 | 331.2 K to 331.1 K (-0.03 %) |
| Mar 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.09 | 100 | 1,109 | 331,187 | 331.3 K to 331.2 K (-0.03 %) |
| Mar 01 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 11.29 | 2,130 | 24,048 | 465,312 | 467.4 K to 465.3 K (-0.46 %) |
| Mar 01 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 11.82 | 2,000 | 23,648 | 467,442 | 469.4 K to 467.4 K (-0.43 %) |
| Mar 01 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 11.40 | 2,000 | 22,800 | 469,442 | 471.4 K to 469.4 K (-0.42 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Sr VP, Operations & ... | Option Exercise | A | 13.16 | 27,079 | 356,360 | 82,079 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Sr VP, Operations & ... | Grant | A | 0.00 | 19,500 | 0 | 27,000 | 7.5 K to 27 K (+260.00 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Financial Off ... | Option Exercise | A | 13.16 | 19,264 | 253,514 | 54,397 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 47,894 | 35.9 K to 47.9 K (+33.43 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Option Exercise | A | 13.16 | 18,984 | 249,829 | 52,984 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Grant | A | 0.00 | 12,000 | 0 | 43,718 | 31.7 K to 43.7 K (+37.83 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Option Exercise | A | 13.16 | 4,247 | 55,891 | 1,504,247 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | M | 10.39 | 1,667 | 17,320 | 98,699 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | X | 8.89 | 3,333 | 29,630 | 100,366 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | A | 13.16 | 18,699 | 246,079 | 103,699 | |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Sell | S | 13.12 | 5,000 | 65,596 | 23,165 | 28.2 K to 23.2 K (-17.75 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 10.39 | 1,667 | 17,320 | 28,165 | 26.5 K to 28.2 K (+6.29 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Buy | M | 8.89 | 3,333 | 29,630 | 26,498 | 23.2 K to 26.5 K (+14.39 %) |
| Feb 08 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Grant | A | 0.00 | 12,000 | 0 | 23,165 | 11.2 K to 23.2 K (+107.48 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.38 | 100 | 1,338 | 331,287 | 331.4 K to 331.3 K (-0.03 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.22 | 100 | 1,322 | 331,387 | 331.5 K to 331.4 K (-0.03 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.07 | 100 | 1,307 | 331,487 | 331.6 K to 331.5 K (-0.03 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.05 | 100 | 1,305 | 331,587 | 331.7 K to 331.6 K (-0.03 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.03 | 100 | 1,303 | 331,687 | 331.8 K to 331.7 K (-0.03 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.01 | 200 | 2,602 | 331,787 | 332 K to 331.8 K (-0.06 %) |
| Feb 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.00 | 300 | 3,900 | 331,987 | 332.3 K to 332 K (-0.09 %) |
| Jan 31 2007 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Exec. VP of Busines ... | Payment of Exercise | F | 13.40 | 1,674 | 22,432 | 31,718 | 33.4 K to 31.7 K (-5.01 %) |
| Jan 26 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.36 | 1,250 | 16,700 | 471,442 | 472.7 K to 471.4 K (-0.26 %) |
| Jan 26 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.41 | 2,000 | 26,820 | 472,692 | 474.7 K to 472.7 K (-0.42 %) |